Page last updated: 2024-08-23

pyrrolidine and Fabry Disease

pyrrolidine has been researched along with Fabry Disease in 1 studies

Research

Studies (1)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	0 (0.00)	29.6817
2010's	0 (0.00)	24.3611
2020's	1 (100.00)	2.80

Authors

Authors	Studies
Cardona, F; Carmona, AT; Goti, A; Kato, A; Kubo, M; Martínez-Bailén, M; Matassini, C; Moreno-Vargas, AJ; Robina, I	1

Other Studies

1 other study(ies) available for pyrrolidine and Fabry Disease

Article	Year
Synthesis of multimeric pyrrolidine iminosugar inhibitors of human β-glucocerebrosidase and α-galactosidase A: First example of a multivalent enzyme activity enhancer for Fabry disease. European journal of medicinal chemistry, 2020, Apr-15, Volume: 192 Topics: alpha-Galactosidase; Cells, Cultured; Dose-Response Relationship, Drug; Enzyme Inhibitors; Fabry Disease; Glucosylceramidase; Humans; Imino Sugars; Molecular Structure; Pyrrolidines; Structure-Activity Relationship	2020

Article

Year

Synthesis of multimeric pyrrolidine iminosugar inhibitors of human β-glucocerebrosidase and α-galactosidase A: First example of a multivalent enzyme activity enhancer for Fabry disease.

European journal of medicinal chemistry, 2020, Apr-15, Volume: 192

Topics: alpha-Galactosidase; Cells, Cultured; Dose-Response Relationship, Drug; Enzyme Inhibitors; Fabry Disease; Glucosylceramidase; Humans; Imino Sugars; Molecular Structure; Pyrrolidines; Structure-Activity Relationship

2020